financing

News

Despite US turmoil, Hinge Health pushes ahead with IPO

Digital health firm Hinge has published a new prospectus for its IPO, shrugging off the weakness in US stock markets caused by Trump's tariffs.

News

Granite Bio makes $100m debut, and other bio financings

Our round-up of recent biotech financings includes rounds for Granite Bio, Biolinq, Etiome, Grove Biopharma, and Synthetic Design Lab.

News

Swiss biotech Veraxa vaults to Nasdaq listing with SPAC deal

Cancer drug developer Veraxa Biotech has reached a deal to merge with a SPAC in a deal that will give it a Nasdaq listing and a $1.6bn-plus valuation.

News

Merida raises $121m for Graves drug, and other financings

Our round-up of recent biotech financings includes rounds for Merida, Glycomine, Attovia, Imbria, and Solu Therapeutics.

News

MoonLake secures $500m for lead drug, plus other financings

MoonLake secures $500m in financing for lead inflammatory disease drug sonelokimab while AIRNA, Atsena, and Neurona complete $100m+ private rounds.

News

Alphabet's Isomorphic raises $600m for AI drug discovery

Isomorphic Labs has raised a whopping $600 million to refine its artificial intelligence-powered drug discovery engine and advance its pipeline.

Despite US turmoil, Hinge Health pushes ahead with IPO

Granite Bio makes $100m debut, and other bio financings

Swiss biotech Veraxa vaults to Nasdaq listing with SPAC deal

Merida raises $121m for Graves drug, and other financings

MoonLake secures $500m for lead drug, plus other financings

Alphabet's Isomorphic raises $600m for AI drug discovery

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

financing

Editor's Picks